Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, talks about how dermatologists are working with artificial intelligence (AI) while still making sure patient voices are heard.
For physicians, patients are the top priority, and something as revolutionary as bringing artificial intelligence (AI) into health care needs to take their perspectives into consideration, said Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center.
Transcript
How can dermatologists incorporate AI into health care without becoming too reliant on it?
I think it's very unlikely that AI is going to take anyone's job in the near future. We're all physicians, we work as doctors. Patients want to be treated by a doctor. But I think AI is going to have a place in health care, really if it's taking over the kind of mundane, day-to-day tasks, as well as a triage tool. In radiology, a lot of AI tools are now FDA-approved, [and there are] triage scans that need to be looked at first by radiologists. I think this will be similar for dermatology, and the pigmented lesions that need to be seen by a dermatologist soon will be the ones that are triaged at the top of the list, particularly in resource-poor areas where people are using much more teledermatology and have less access to dermatologists.
There's also the concept of augmented intelligence, which is where doctors are working alongside artificial intelligence. I think this is the place that's also going to have a role. It's been shown to be useful for primary care as well as in training residents and helping them make decisions. There's a research paper that was shown that when people make their decision with a relatively poor confidence, that's the place that augmented intelligence can come in and help us in making management plans for our patients.
With the popularization of AI, how can patients ensure their voice is still being heard?
This is a really important point. I mean, we're physicians, and patients are the first thing that should be important to us. So, we really can't be bringing anything as revolutionary as AI into health care without taking patients' perspectives into account. There has been some research surveying patients on their opinions on AI, which is very mixed—people tend to be supportive of it, but they really don't want to lose that personal aspect of medicine. And quite worryingly, research has shown that it's the people with higher education, higher income level that are going to be more accepting of AI, and that's a concern because we really don't want to bring in anything that's going to perpetuate inequalities in health care. So I think before anyone is really developing tools that are going to be rolled out to the public or be implemented to health care systems, we really need to ensure there's some patient public engagement in there before we do that.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost
April 8th 2025Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ruxolitinib cream for atopic dermatitis and the potential for phototherapy to delay costly biologic initiation.
Read More
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More